HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Leukotrienes as mediators in ischemia-reperfusion injury in a microcirculation model in the hamster.

Abstract
Leukotriene (LT)B4 promotes leukocyte chemotaxis and adhesion to the endothelium of postcapillary venules. The cysteinyl leukotrienes, LTC4, LTD4, and LTE4, elicit macromolecular leakage from this vessel segment. Both leukocyte adhesion to the endothelium and macromolecular leakage from postcapillary venules hallmark the microcirculatory failure after ischemia-reperfusion, suggesting a role of leukotrienes as mediators of ischemia-reperfusion injury. Using the dorsal skinfold chamber model for intravital fluorescence microscopy of the microcirculation in striated muscle in awake hamsters and sequential RP-HPLC and RIA for leukotrienes, we demonstrate in this study that (a) the leukotrienes (LT)B4 and LTD4 elicit leukocyte/endothelium interaction and macromolecular leakage from postcapillary venules, respectively, that (b) leukotrienes accumulate in the tissue after ischemia and reperfusion, and that (c) selective inhibition of leukotriene biosynthesis (by MK-886) prevents both postischemic leukotriene accumulation and the microcirculatory changes after ischemia-reperfusion, while blocking of LTD4/E4 receptors (by MK-571) inhibits postischemic macromolecular leakage. These results demonstrate a key role of leukotrienes in ischemia-reperfusion injury in striated muscle in vivo.
AuthorsH A Lehr, A Guhlmann, D Nolte, D Keppler, K Messmer
JournalThe Journal of clinical investigation (J Clin Invest) Vol. 87 Issue 6 Pg. 2036-41 (Jun 1991) ISSN: 0021-9738 [Print] United States
PMID1645749 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Leukotrienes
  • SRS-A
  • Leukotriene B4
Topics
  • Animals
  • Blood Flow Velocity
  • Cell Adhesion
  • Cricetinae
  • Endothelium, Vascular (cytology)
  • Leukocytes (cytology)
  • Leukotriene B4 (pharmacology)
  • Leukotrienes (physiology)
  • Microcirculation (drug effects)
  • Models, Biological
  • Muscles (blood supply)
  • Reperfusion Injury (physiopathology)
  • SRS-A (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: